BSE filing, NSE: DARSHANORNA. Summary written from the filing by ALFA Finder's alert engine.
Darshan Orna Ltd: key numbers
- Share price
- ₹1.98
- Market cap
- ₹19.81 Cr
- Revenue (annual)
- ₹71.49 Cr
- Net profit (annual)
- ₹0.65 Cr
- P/E (TTM)
- 40.7×Sector 49.5×
- Promoter holding
- 34.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Darshan Orna Ltd
All →Darshan Orna Board Meeting Date
Darshan Orna has scheduled a board meeting on 2 November 2026 to consider unaudited standalone results for the half year ended September 2026. The trading window stays closed until 48 hours after results are declared.
Darshan Orna Management Change
Darshan Orna Limited has appointed Ms. Heena Arvind Rawal as the new Company Secretary and Compliance Officer, effective October 21, 2026.
Darshan Orna Other Announcement
Darshan Orna Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Darshan Orna Other Announcement
Darshan Orna Ltd has appointed M/s P H Shah and Co. as its Statutory Auditor for a five-year term, effective from FY 2026-27.
- Execution
- 5 years
Darshan Orna Annual General Meeting
Darshan Orna Limited held its 15th Annual General Meeting on 25th September, 2026, via video conferencing. The meeting transacted routine business as per the notice.
Darshan Orna Annual General Meeting
Darshan Orna Limited has scheduled its 15th Annual General Meeting for September 25, 2026. It has also released the Integrated Annual Report for FY 2025-26.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.